Dallas, Texas (PRWEB) December 18, 2014
The rise in prevalence of degenerative diseases is one of the main factors which is driving the growth of the global regenerative medicine market. Regenerative medicine is involved in the process of replacing or regenerating human tissues, cells and/or organs for normal functioning of the body. Small molecules and biologics, gene therapy, and cell therapy are the three main technologies which are used in regenerative medicine. The global market is expected to grow at a compound annual growth rate of 20.16% during the period from 2014 to 2019. Increase in demand for regenerative products and an increase in research and development are also fueling the growth in the global regenerative medicine market.
Key players in the global market for regenerative medicine are Medtronic, Baxter International, Stryker, and Kinetic Concepts. Other important vendors in the market include Aastrom Biosciences, Acologix, Advanced Cell Technology, Arteriocyte, Athersys, Avita Medical, Bacterin International, Bellicum Pharmaceuticals, Bioactive Regenerative Therapeutics, BioCardia, BioLife Solutions, CryoLife, Cynata Therapeutics, Cytomedix, Cytori Therapeutics, Fibrocell Science, Forticell Bioscience, GE Healthcare, Geron, Histogenics, Humacyte, Integra Life Sciences, InVivo Therapeutics, Kensey Nash, MaxCyte, Mesoblast, Nanofiber Solutions CTO, NeoStem, Neuralstem, Olympus Terumo Biomaterials, Opexa Therapeutics, Organogenesis, Osiris Therapeutics, Osteotech, Pluristem Therapeutics, ReNeuron Group, RTI Biologics, SanBio, StemCells, Tengion, Thermo Fischer Scientific, Tissue Genesis, and ViaCyte. Companies are increasing their investment in R&D for regenerative products as well as developing innovative therapies. Although the global regenerative medicine market is highly fragmented, an increase in the number of mergers and acquisitions is an emerging trend in the market. One of the biggest challenges in the market is a stringent regulatory approval process.
Order a copy of this report at (Prices start at US $2500 for a single user PDF) http://www.reportsnreports.com/purchase.aspx?name=320608. Alternatively, get a discount at http://www.reportsnreports.com/contacts/discount.aspx?name=320608.
The global regenerative medicine market can be segmented according to application, technology and geographical regions. On the basis of application, the market can be segmented into orthopedic tendon and ligament, chronic and acute wounds, plastic and reconstructive surgery, cardiology, breast reconstruction, osteoarthritis, general surgery, trauma, hernia repair, burns, urology, and urogyneocology. By technology, the market can be segmented into small molecules and biologics, cell therapy, and gene therapy. An increase in the prevalence of diseases like Parkinson’s, diabetes, Alzheimer’s and cancer has also resulted in considerable investments in research and development of regenerative products.
The report Global Regenerative Medicine Market 2015-2019 is an in-depth and professional report, that covers market overview, market size and forecast, product offerings, growth prospects, drivers and their impact, key trends, opportunities, challenges, threats, key vendors, and strengths and weaknesses of key vendors.
End of Year Discounts: A discount of 20% on all reports published by Infiniti Research Limited, until the 24th of September 2014. Discount available till 15th January 2015.
Other Related Reports:
Stem Cell Research Products - Opportunities, Tools, and Technologies: Full-year 2013 analysis determines the size of the stem cell research products market to be $3.22 billion, and the stem cell therapies market to be $3.31 billion, for a total of $6.53 billion. In addition, both markets are growing with double-digit growth. Producing stem cell research products, thus represent a massive profit opportunity for research supply companies. Inquire for Discount at http://www.reportsnreports.com/contacts/discount.aspx?name=10597 (Single User License of the report is US $3495).
Global Biologic Therapeutics Market 2014-2018: Analysts forecast the Global Biologic Therapeutics market to grow at a CAGR of 8.22 percent over the period 2013-2018.
The report covers the present scenario and the growth prospects of the Global Biologic Therapeutics market for the period 2014-2018. To calculate the market size, the report considers revenue generated through the sales of the following drugs:
- Protein Therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics)
- Vaccines (pediatric vaccines and adult vaccines)
- Cell therapy
The Other Protein Therapeutics segment covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.
Regenerative Medicine Partnering Terms and Agreements Key Benefits:
- In-depth understanding of regenerative medicine and stem cells deal trends since 2009
- Includes cell therapy, organ regeneration, stem cells and tissue regeneration deals
- Access to headline, upfront, milestone and royalty data
- Analysis of the structure of regenerative medicine and stem cells agreements with numerous real life case studies
- Comprehensive access to actual regenerative medicine and stem cells contracts entered into by the world's biopharma companies, together with real world clause examples
- Full listing of regenerative medicine and stem cells deals by company A-Z, deal value, deal type, and therapy focus
- And much more.
ReportsnReports.com is an online market research reports library of 500,000+ reports and in-depth studies of 5000+ micro markets. Call +1 888 391 5441 with your industry research requirements or email the details on sales at reportsandreports.com.